Cyclosporine/PUVA approach to psoriasis raises cancer risk

December 1, 2001

Boston - Use of the immunosuppressant cyclosporine on patientswith psoriasis who have had substantial psoralen and ultra violet A lighttreatments show a sevenfold increase in the number of squamous cell cancertumors, according to Robert S. Stern, M.D.